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Abstract 1 
Poor postprandial glucose control is a risk factor for multiple health conditions. The second-meal 2 
effect refers to the progressively improved glycaemic control with repeated feedings, an effect which 3 
is achievable with protein ingestion at the initial eating occasion. The most pronounced glycaemic 4 
response each day therefore typically occurs following breakfast, so this study investigated whether 5 
ingesting protein during the night could improve glucose control at the first meal of the day. In a 6 
randomised cross-over design, fifteen adults (7 males, 8 females; age, 22 ± 3 years; BMI, 24.0 ± 2.8 7 
kg·m-2; fasting blood glucose, 4.9 ± 0.5 mmol·L-1) woke at 0400 ± 1 h to ingest 300 ml water with or 8 
without 63 g whey protein. Participants then completed a mixed-macronutrient meal tolerance test (1 9 
g carbohydrate·kg body mass-1, 563 ± 104 kcal,) 5 h 39 min following the nocturnal feeding. 10 
Nocturnal protein ingestion increased the glycaemic response (incremental area under curve) to 11 
breakfast by 43.5 ± 55.5 mmol•120 min•L-1 (p=0.009, d=0.94). Consistent with this effect, individual 12 
peak blood glucose concentrations were 0.6 ± 1.0 mmol·L-1 higher following breakfast when protein 13 
had been ingested (p=0.049, d=0.50). Immediately prior to breakfast, rates of lipid oxidation were 14 
0.02 ± 0.03 g·min-1 higher (p=0.045) in the protein condition, followed by an elevated postprandial 15 
energy expenditure (0.09 ± 0.12 kcal·min-1, p=0.018). Postprandial appetite and energy intake were 16 
similar between conditions. This study reveals a paradoxical second-meal phenomenon whereby 17 
nocturnal whey protein feeding impaired subsequent glucose tolerance, whilst increasing 18 
postprandial energy expenditure. 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
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INTRODUCTION 31 
The postprandial glycaemic response to a fixed carbohydrate load can be used to assess the 32 
proficiency of glucose control(1). Repetitive and/or prolonged hyperglycaemic episodes are linked to 33 
a heightened risk of multiple health conditions including: type 2 diabetes mellitus, cardiovascular 34 
disease and ultimately premature mortality(2). Ineffective postprandial glucose tolerance also impairs 35 
satiety perception and is thus linked to obesity, a key risk factor for type 2 diabetes(3; 4). Even amongst 36 
normoglycemic individuals (5), those with poorer postprandial glycaemic control are at increased risk 37 
of developing type 2 diabetes and cardiovascular disease(6). The prevalence of these morbidities is 38 
increasing and presents a large personal and socio-economic burden (3; 7). Several clinical markers are 39 
available to diagnose defective glucose control; incremental area under the blood glucose 40 
concentration curve (iAUC) reflects the response to a glucose challenge and provides a more valid 41 
indication of glucose tolerance than basal/fasted measures alone (2; 8). This is entirely understandable 42 
given that the time spent hyperglycaemic is a primary factor in the aetiology of diabetic 43 
complications(9; 10). 44 
 Beyond the internal validity of postprandial glycaemia as a measure of glucose control, the 45 
external validity of fasted (i.e. post-absorptive) measures is also more limited given that typical eating 46 
patterns in most societies mean that humans spend most or all waking hours in a fed-state (i.e. post-47 
prandial)(9; 11). Of even greater practical relevance is the response to sequential meals, as most meals 48 
are therefore consumed in an already postprandial state. The ‘second-meal effect’ describes how 49 
initial glucose ingestion improves glucose tolerance at a second eating occasion (12). Whilst this 50 
phenomenon was first discovered with sequential oral glucose tolerance tests (OGTT), a more 51 
ecologically valid method considers the effect of the mixed-macronutrient meals. This has been most 52 
commonly examined in the literature as the magnitude of metabolic responses to lunch when 53 
breakfast is consumed, comparative to no breakfast(8). Notably, this effect also promotes a more even 54 
glycaemic stability across the day, thus eliciting a potentially beneficial effect on satiety 55 
perception(13). The second-meal effect is hypothesised to involve several interacting mechanisms, 56 
such as enhanced hepatic and peripheral insulin sensitivity, potentiated insulin secretion, and slowed 57 
gastric emptying following ingestion of a second meal(14). 58 
 Whereas the influence of carbohydrate (CHO) and fat on second-meal effects are relatively 59 
well understood (i.e. high-CHO, low-glycaemic index (GI) and low-fat breakfasts are effective in 60 
optimising the insulin secretion and glycaemic response to lunch(15; 16; 17; 18)), the efficacy of protein 61 
has received less research attention. Several studies have demonstrated that protein, specifically 62 
whey, consumed as a preload can elicit the second-meal effect (19; 20; 21). This has been attributed to 63 
augmented insulin secretion and insulin priming of the muscle and liver, alongside delayed gastric 64 
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emptying of the second load (20; 21). Protein ingestion has also been linked to appetite suppression and 65 
a reduction in subsequent energy intake(4; 20; 22), although other studies report no such effects (19; 23). 66 
In addition, recent evidence suggests that a high-protein breakfast may be a more potent stimulator 67 
of the second-meal effect than a high-CHO breakfast(24; 25), although this possibility requires 68 
confirmation in young, normoglycaemic populations. Moreover, previous studies have only 69 
examined the carry-over effects between the established daily sequence of eating occasions (i.e. 70 
breakfast-lunch-dinner), yet a novel strategy would be to attenuate the profound first glycaemic 71 
response after waking using a model wherein breakfast serves as the second meal of the day. 72 
 The purpose of this study, therefore, was to examine the effect of nocturnal whey protein 73 
ingestion on the glucose response to breakfast, alongside any secondary effects on subsequent satiety 74 
and energy intake later in the day. Based on extant literature examining the effects of prior feeding 75 
during the morning on metabolic responses to lunch, we hypothesised that protein ingestion will 76 
attenuate the glycaemic response to breakfast and reduce subsequent appetite and energy intake.  77 
 78 
EXPERIMENTAL METHODS  79 
Approach to the research question 80 
The innovative nature of this investigation stems from the unique combination of protein 81 
ingestion with nocturnal feeding. Whey protein was chosen in preference to alternative protein 82 
sources due to a shorter gastric emptying time, resulting in a more rapid development and greater 83 
magnitude of hyperaminoacidaemia and therefore a more rapid insulin release. This is consistent with 84 
the rationale for our stated hypothesis above, that an increased morning insulin requirement is due to 85 
a lack of residual insulin from a preceding meal(26). As such, this novel strategy may reduce the insulin 86 
requirement to breakfast, consequently improving glucose control.  87 
Whey also reduces subsequent food intake and appetite to a greater extent than casein, egg or 88 
soy(20; 26; 27). A whey protein dose between 20-40 g can be effective in reducing appetite, while as 89 
little as 10 g is reported to stimulate the second-meal effect(20). A large, but palatable dose of 63 g 90 
was used in this novel protocol to conclusively elucidate any effects on sequential glycaemic response 91 
and satiety (i.e. if effects are observed then that provides proof-of-principle and could warrant further 92 
examination of lower doses). This protein solution was made up with 300 ml of water instead of milk 93 
to avoid  confounding effects of fat ingestion and to allow any effects of protein to be isolated.  94 
The time of protein feeding was 0400 ± 1 h to ensure a post-absorptive state following dinner 95 
and to allow sufficient time before breakfast for the acute initial metabolic response to the ingested 96 
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protein to subside. The time of feeding resulted in, on average, a 5 h 39 min period between protein 97 
ingestion and breakfast, which aligns with the majority of studies investigating the second-meal effect 98 
using 3-6 h between sequential meals(13; 18; 28; 29). Additionally, participants were instructed to be in 99 
bed, lights out, at 23:00, which would therefore result in a minimum of 5 h separating dinner and the 100 
nocturnal protein feed. A mixed macronutrient tolerance test was deemed more appropriate than an 101 
OGTT as this study focuses on the response to sequential meals to provide practical results applicable 102 
to daily living. A porridge breakfast aligns with this aim as a common breakfast meal, providing 103 
information on the ability to process a realistic glucose and fat challenge.  104 
 105 
[Figure 1] 106 
 107 
Participants 108 
Fifteen individuals who self-identified as healthy volunteered to participate (7 males, 8 109 
females; age, 22 ± 3 years; BMI, 24.0 ± 2.8 kg•m-2; resting heart rate, 69 ± 15 bpm; resting mean 110 
arterial pressure, 72 ± 6 mmHg; fasting blood glucose, 4.9 ± 0.5 mmol•L-1; sleep chronotype, 54 ± 7 111 
(intermediate)). Participants were informed of the study objectives, requirements and any potential 112 
risks before written consent was obtained. Ethical approval was received from the University of Bath 113 
research ethics committee (SESHES-18R1-004). Exclusion criteria included allergy or intolerance to 114 
any of the breakfast constituents or any metabolic conditions which may have posed undue personal 115 
risk to the participant or introduced bias into the experiment. 116 
 117 
Study design 118 
This study employed a randomised crossover design, comprising two conditions; nocturnal 119 
ingestion of either a protein solution (PRO) or water (CON). The following morning participants 120 
visited the laboratory to complete a mixed-macronutrient meal tolerance test. Participants were not 121 
blinded to the condition as it would have been immediately apparent upon ingestion and to analyse 122 
subsequent food choices participants needed to be aware of their consumption as they would in free-123 
living conditions. Trials were completed within a month for males, or within 4-7 days for females to 124 
ensure the phase of the menstrual cycle was consistent between trials in order to avoid large 125 
systematic differences in glucose control due to menstrual cycle phase(30). All procedures were 126 
performed in accordance with the declaration of Helsinki. 127 
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Experimental procedures 128 
Participants refrained from vigorous physical activity and replicated their diet the day prior to 129 
both laboratory visits. Compliance was confirmed verbally upon laboratory arrival. A schematic for 130 
the study protocol is shown in Figure 2. Prior to data collection, participants completed the Horne & 131 
Östberg Morningness-Eveningness Questionnaire(31), to assess sleep chronotype and establish 132 
habitual morning or evening preference. Participants were instructed to be in bed, lights out at 23:00, 133 
awaking at 07:00 and arriving in the laboratory the following morning at 09:00. Participants awoke 134 
at 04:00 to consume the relevant solution. Compliance was confirmed with a text message to a 135 
researcher at this time. Based on the questionnaire results, these time components were adjusted ± 1 136 
h for morning or evening preference. This aimed to minimise disturbance to habitual sleep patterns 137 
due to the confounding effect on glucose tolerance(32). 138 
Upon laboratory arrival the following morning, anthropometric (height and mass) and pre-139 
breakfast resting measures were collected. Fingertip blood glucose concentration was recorded using 140 
an automatic glucose analyser (coefficient of variation 5.03%) (FreeStyle Optium, Abbott 141 
Laboratories Ltd, Berkshire, UK). Three 5 min expired gas samples were collected using Douglas 142 
bags (Hans Rudolph, MO, USA), which were analysed using a Servomex 1440 Gas Analyser 143 
(Servomex Group Ltd., UK) and the volume of expired air determined by evacuating the Douglas bag 144 
with a dry gas meter (Harvard Apparatus, Kent, UK). Heart rate and blood pressure (Omron M2 145 
Compact blood pressure monitor, Omron Healthcare Co., Netherlands) were collected, alongside 100 146 
mm visual analogue scales. 147 
A standardised porridge breakfast was then consumed, followed by a 2 h resting period in the 148 
seated position with water consumption permitted (ad libitum). Blood glucose measurements were 149 
collected every 15 min for the first 60 min and then every 30 min until 120 min. Five min expired air 150 
samples were collected at 20, 40, 75 and 100 min. At 60 and 120 min appetite VAS were completed. 151 
Upon completion of the tolerance test participants were free to leave the laboratory and completed a 152 
food diary for the remainder of the day under free-living conditions. 153 
 154 
[Figure 2] 155 
 156 
 157 
 158 
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Nutritional composition 159 
Experimental solutions were prepared by researchers and provided to participants the night 160 
before the trial. The protein solution contained: 75 g whey protein powder (Myprotein, Northwich, 161 
UK), resulting in an intake of 63 g protein (21 g protein per 25 g serving), 300 ml water and 0 kcal 162 
vanilla flavouring drops to taste (Myprotein, Northwich, UK). An amino acid profile for the whey 163 
protein used is depicted in Figure 1. The control solution was 300 ml water. Breakfast consisted of 164 
29% porridge oats (Sainsbury’s, UK), 67% whole milk (3.7/100 g fat; Sainsbury’s, UK) and 4% 165 
granulated sugar (Sainsbury’s, UK). Porridge was provided in quantities to deliver 1 g CHO·kg body 166 
mass-1, obtained from 80% oats and 20% sugar. This resulted in an energy intake of 563 ± 104 kcal, 167 
containing 18.0 ± 3.3 g protein and 72.4 ± 13.9 g CHO. The quantity was replicated for the second 168 
trial, regardless of any minor change in body mass. Participants were instructed to consume the 169 
porridge within 15 min to standardise effects of eating rate upon appetite hormones(33). 170 
 171 
Statistical analysis 172 
All data are presented as mean ± standard deviation. Statistical analyses were performed using 173 
the Statistical Package for the Social Sciences (IBM SPSS Statistics 25), with statistical significance 174 
accepted at an alpha level of p≤0.05. A minimum sample size of 11 was calculated in order to detect 175 
an effect size of 0.95 with 80% power (G*Power 3.1.9.4), based on the effect size in similar studies 176 
in normoglycaemic individuals (24; 34). Data from one female participant who volunteered for the study 177 
were not included in the analysis because she experienced very poor sleep quantity in the control 178 
condition (>2 SD below the mean), given the established negative effect of sleep deprivation on 179 
glucose tolerance(32). This is illustrated by her almost doubled blood glucose iAUC in the CON 180 
condition (396 versus 195 mmol·120min·L-1). 181 
Blood glucose iAUC was calculated using the trapezoid method(35). Rates of oxygen 182 
utilisation and carbon dioxide production were used to calculate respiratory exchange ratio (RER) 183 
and energy expenditure from expired gas samples(36). Substrate oxidation rates were calculated in 184 
accordance with the stoichiometric equations outlined by Frayn (37) assuming negligible protein 185 
oxidation. Of the three resting gas samples, the average of those within a 100 kcal• day-1 agreement 186 
in energy expenditure was taken to calculate pre-breakfast values of substrate utilisation, RER and 187 
energy expenditure. If none of the three bags met this criterion, the lowest of the three samples was 188 
considered the most reflective measure of resting metabolic rate (this was the case for 5 out of 27 189 
bags). Scores from the appetite VAS were combined to give an average appetite score at each time 190 
point according to the equation outlined by Gonzalez and Stevenson (8). Regarding sleep VAS, a 191 
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difference >10 mm is deemed of clinical relevance and more meaningful than statistical 192 
significance(38), and thus this criterion was used when examining intraindividual differences in VAS 193 
scores between conditions. 194 
 A Shapiro-Wilk test was used to assess the normality of intraindividual differences between 195 
conditions. Consequently, a paired t-test was applied to analyse normally distributed parametric data 196 
and a Wilcoxon test used for non-parametric data. Order effects were examined with a paired t test 197 
for iAUC between trial 1 and 2 alongside a two-way mixed-models ANOVA (treatment x sequence); 198 
there was a 2.2% decrease in iAUC from trial 1 to 2 with no significant order effect (p=0.875) and no 199 
treatment x sequence interaction (p=0.509, F=0.463). Pearson correlation coefficients were calculated 200 
for the difference in iAUC between conditions and both body mass and sleep quality (calmness and 201 
wakefulness). A two-way repeated measures ANOVA (treatment x time) was used to examine 202 
differences in blood glucose response and appetite over time. The Greenhouse-Geiser correction was 203 
applied for epsilon values <0.75 and the Huynd-Feldt correction applied for less severe asphericity. 204 
Effect size was calculated using pooled standard deviation, with Cohen’s thresholds applied(39). 205 
 206 
 207 
RESULTS 208 
Blood glucose concentration 209 
Plasma glucose concentrations increased more rapidly in PRO than in CON, reaching a 7.5% 210 
higher peak (7.9 ± 1.4 versus 7.3 ± 0.9 mmol•L-1, p=0.049, d=0.50, moderate effect; Figure 3A) and 211 
then remaining higher than the CON trial until the final blood sample, such that there was a main 212 
effect of treatment (p=0.037, F=5.392) but no treatment x time interaction (p=0.308, F=1.241; Figure 213 
4). Accordingly, there was a 28.1% mean increase in postprandial blood glucose iAUC in the PRO 214 
condition (161.8 ± 55.7 v 116.3 ± 39.2 mmol•120 min•L-1 (p=0.009, d=0.94; Figure 3B). Time spent 215 
above the clinical threshold of 7.5 mmol•L-1 blood glucose concentration was longer in the PRO trial 216 
for 9 out of 14 participants by an average of 8.2 ± 13.4 min (15.9 ± 17 v 7.7 ± 11.6 min, p=0.039, 217 
d=0.56, moderate effect). Although not significant (p=0.206, d=0.48, small effect), on average there 218 
was a 6.4 ± 18.3 min delay in time to peak glucose with PRO (37.5 ± 16.4 min) compared to CON 219 
(31.1 ± 9.2 min). 220 
 221 
[Figure 3] 222 
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[Figure 4] 223 
 224 
Substrate utilisation, respiratory exchange ratio and energy expenditure 225 
Lipid oxidation was 30.8% greater at pre-breakfast (following intervention but prior to the 226 
test meal) in the PRO trial compared to CON (p=0.045) (Table 1). There were no significant 227 
differences between conditions at pre-breakfast for RER, CHO oxidation, or energy expenditure. 228 
Mean responses over the 120 min postprandial period did not differ between conditions for RER, 229 
CHO oxidation, or lipid oxidation. Postprandial energy expenditure was greater in the PRO trial 230 
(p=0.018). 231 
 232 
[Table 1] 233 
 234 
Subjective appetite and energy intake 235 
There were no significant differences in any appetite ratings or combined appetite score at 236 
pre-breakfast (all p>0.05, Table 2). There was a main effect of time (p<0.001, F=11.411), but not 237 
treatment (p=0.674, F=0.185) nor treatment x time interaction (p=0.681, F=0.222) for postprandial 238 
combined appetite score. Further, there was a main effect of time (p<0.03), but not treatment nor 239 
treatment x time interaction (all p>0.05), for hunger, fullness, satisfaction and prospective 240 
consumption during the postprandial period. There was no difference in volitional energy intake 241 
(p=0.736) in CON (1728 ± 681 kcal) compared to PRO (1666 ± 766 kcal). 242 
 243 
[Table 2] 244 
 245 
Sleep quantity and quality 246 
There was no difference in self-reported sleep quantity between conditions (450 ± 52 v 444 ± 247 
52 min, p=0.788). Reductions >10 mm were observed in the sleep quality measures of wakefulness 248 
(15 mm) and calmness (12 mm) in the PRO versus CON condition. However, there was no correlation 249 
between the difference in iAUC between conditions and the change in sleep wakefulness (r=0.017, 250 
p=0.953) or calmness (r=0.176, p=0.546) between trials. 251 
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DISCUSSION 252 
This is the first study to investigate nocturnal protein ingestion in relation to the second-meal 253 
effect at breakfast. Contrary to our hypothesis, the primary findings demonstrate impaired 254 
postprandial glucose tolerance at breakfast after nocturnal protein ingestion, evidenced by the 255 
increased glycaemic response (iAUC) and peak blood glucose concentrations. Pre-breakfast (fasted) 256 
lipid oxidation was also elevated following protein ingestion, whilst postprandial after breakfast 257 
energy expenditure was higher. There was no difference in appetite or volitional energy intake 258 
between conditions. These findings illustrate that protein elicited a response opposite to the second-259 
meal effect, impairing sequential glucose tolerance, with no effect on appetite or energy intake. This 260 
is the opposite response to that reported in the available literature regarding daytime meals during 261 
waking hours(15; 16; 18; 20). 262 
The differences in glucose tolerance observed in the present study may be due to the 63 g dose 263 
of protein, as the majority of studies demonstrating a beneficial effect of a protein preload have used 264 
doses in the range of 10-55 g(19; 20; 21). Further, previous studies have most commonly utilised a protein 265 
preload 30 min prior to the second meal (19; 20; 21), which differs from 5 h 39 min separating meals in 266 
the present study. Although both Meng et al. (24) and Park et al. (25) demonstrated that protein 267 
stimulates the second-meal effect with 4 h separating meals, both studies used high-protein breakfast 268 
foods, rather than the addition of whey protein used in the aforementioned preload studies(19; 20; 21). 269 
Moreover, these studies were conducted in adults with type 2 diabetes(25) and postmenopausal 270 
women(24). Regarding appetite, our results support the findings of Allerton et al. (28), which also 271 
reported no attenuation in appetite when whey protein was added to breakfast(28) ingested with a 272 
longer duration (i.e. 3 h) between meals than used in other preload studies(19; 20; 21). 273 
 Protein ingestion in excess of physiological needs can stimulate ureagenesis and the use of 274 
glucogenic amino acids in gluconeogenesis(40). Boden and Tappy (41) demonstrated the 275 
hyperaminoacidemia following protein ingestion stimulated endogenous glucose production despite 276 
hyperinsulinemia. Studies employing stable isotope methodologies have demonstrated ~17-19% of 277 
protein ingested is converted to glucose(42; 43). Therefore, assuming similar rates in the current study, 278 
it could be hypothesised that 17-19% of the 63 g protein ingested in the current study resulted in 279 
glucose production, producing 10.7 – 12.0 g glucose. This is supported by the findings of Ang et al. 280 
(44), who demonstrated that a 75 g of whey protein dose resulted in 11 g endogenous glucose 281 
production. Fromentin et al. (42) state that the percentage of dietary amino acids converted to glucose 282 
was mainly related to the provision of glucogenic amino acids. The whey protein utilised in this study 283 
comprised 79.8/100 g glucogenic or mixed amino acids (Figure 1), providing a high availability of 284 
gluconeogenic precursors. In addition, the relative lack of other sources of gluconeogenic precursors 285 
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(glycerol, pyruvate, lactate) in our whey protein solution, comparative to egg(42) or cottage cheese(43), 286 
may have further increased the contribution of amino acids to gluconeogenesis. Hence, glucose 287 
production may have been at the higher end of this estimate. 288 
 There are multiple underlying mechanisms through which the above-reasoned endogenous 289 
glucose production could alter glucose control following breakfast. Firstly, it may be that there was 290 
still some residual endogenous glucose production from the nocturnal protein by the time breakfast 291 
was ingested. Indeed, Ang et al. (44) reported that endogenous glucose production was still elevated 292 
at 4 h following whey protein ingestion, which could therefore supplement the carbohydrate directly 293 
ingested at breakfast and thus explain the elevated postprandial glycaemia in the PRO condition. It 294 
should be noted, however, that the breakfast in the present study was provided almost 6 h following 295 
the protein dose, so the contribution of the ingested protein towards endogenous glucose production 296 
may have subsided by the time of the second delivery of ingested nutrients.  297 
 Secondly, any glucose generated from the ingested amino acids even prior to breakfast could 298 
still contribute to a more positive carbohydrate balance (i.e. increased glycogen availability) and thus 299 
potentially limit the capacity for further non-oxidative carbohydrate disposal at breakfast. Certainly 300 
the 10-12 g of glucose that would theoretically arise via gluconeogenesis from the ingested protein 301 
could make a meaningful contribution towards the total capacity for hepatic glycogen stores. The 302 
current study employed a somewhat unusual protocol in that a large provision of energy was delivered 303 
at an atypical time of day when neither required nor expected by the body. Overnight fasting depletes 304 
hepatic glycogen stores and stimulates gluconeogenesis(45; 46), hence the liver may have been more 305 
sensitive to the large protein dose ingested during the night. It is unlikely that any large proportion of 306 
glucose produced would be oxidised in this rested and fasted state and therefore is more likely to be 307 
stored, increasing hepatic glycogen stores. An increase in glycogen stores may reduce the liver’s 308 
capacity for first pass extraction following breakfast, reducing hepatic glucose uptake and resulting 309 
in more glucose remaining in circulation(47). In the present study, the mean time between protein 310 
ingestion and breakfast was 5 h 39 min. Peak liver glycogen concentration is achieved around 5 h 311 
postprandially(46), therefore it is possible this peak may have coincided with breakfast, reducing the 312 
capacity for first pass extraction. However, rather than liver glycogen storage, the primary driver of 313 
postprandial glucose tolerance is thought to be insulin-stimulated glucose uptake into peripheral 314 
tissues and the synthesis of skeletal muscle glycogen(48; 49), yet 10-12 g of newly synthesised glucose 315 
would represent a much smaller contribution to whole-body muscle glycogen reserves and thus less 316 
likely to impair skeletal muscle glucose uptake at breakfast. The present results regarding glycaemic 317 
control therefore warrant future studies to examine such mechanisms by measuring glucose 318 
synthesis/disposal, along with muscle and liver glycogen concentrations. 319 
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 The time of feeding in the present study may also have impacted gluconeogenesis and insulin 320 
sensitivity. Protein was fed at a time when the relative concentrations of both glucagon and cortisol 321 
were increasing. Elevated glucagon concentration stimulates hepatic gluconeogenesis and amino acid 322 
uptake(50; 51), while cortisol also stimulates hepatic gluconeogenesis, alongside reducing insulin 323 
sensitivity(50). Betts et al. (52) demonstrated that the overnight cortisol response is elevated following 324 
the co-ingestion of protein with CHO before bed. Thus, the protein ingestion in the present study may 325 
have augmented the natural circadian elevation in cortisol thus reducing insulin sensitivity. There is 326 
also evidence for circadian rhythmicity in circulating amino acids, with lowest concentrations 327 
between 0400 and 0800 h(53; 54). Feigin et al. (54) demonstrated that the ingestion of a large protein 328 
bolus at 0800 h resulted in an additional increase in blood amino acid concentrations, exceeding that 329 
anticipated from typical circadian periodicity, an interference not replicated with an identical protein 330 
load consumed at 2000 h. This further supports the idea that the body may not be entrained to deal 331 
with a large bolus protein dose at the time of feeding in the present study. Finally, whey protein 332 
ingestion and an increase in plasma branched-chain amino acids (BCAA), particularly leucine, have 333 
also been demonstrated to impair insulin sensitivity directly, especially in high doses (55; 56; 57). The 334 
high BCAA (22.6/100 g) and specifically leucine content (10.6/ 100 g) of the whey protein (Figure 335 
1) may therefore have impaired glucose uptake via that mechanism. As such, any priming effect of 336 
insulin secretion following protein ingestion may have been insufficient to overcome this reduced 337 
insulin sensitivity at breakfast. Therefore, the arrival of a large dose of amino acids at an atypical time 338 
of day might, via the hypothesised influence on hepatic gluconeogenesis and insulin sensitivity, result 339 
in impaired glucose control upon waking in a manner specific to this time-frame. This further 340 
highlights the novel nature of the current study employing an atypical feeding time. Additional study 341 
is warranted to investigate if the glucose tolerance to a second meal is impaired following protein 342 
ingestion prior to other daily meals in a more ‘conventional’ feeding pattern. 343 
Pre-breakfast lipid oxidation was elevated in the PRO trial and post-prandial energy 344 
expenditure was also then higher. It should be noted, however, that these calculations were not 345 
adjusted based on 24-h nitrogen excretion and so assume negligible protein oxidation, which may not 346 
be a valid assumption in this experiment(37). Witard et al. (58) reported that ingesting 40 g whey protein 347 
isolate stimulates phenylalanine oxidation for 4 h, so the 63 g ingested in the present study is likely 348 
to have stimulated a similar response, although this may have reduced by the time measurements 349 
were made 6 h later at breakfast. Nonetheless, if protein undergoes gluconeogenesis and is oxidised, 350 
then the respiratory quotient for that process is ~0.8 (the same as for direct protein oxidation), whereas 351 
the respiratory quotient if the newly synthesised glucose is stored is 0.4(59). Any persistent protein 352 
oxidation or gluconeogenesis 6 h after the nocturnal bolus would therefore be expected to slightly 353 
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reduce the whole-body RER based on measured oxygen uptake and carbon dioxide production. 354 
However, the fact that the RER under both conditions were very similar and in the range of 0.85-0.89 355 
means any such difference is likely to be small and thus it remains a reasonable alternative explanation 356 
that the ingested protein did in fact increase lipid oxidation. 357 
 In conclusion, consumption of a whey protein solution during the night impaired postprandial 358 
glucose control at breakfast, whilst increasing postprandial energy expenditure, with no effect on 359 
satiety or energy intake. As such, this approach would not be recommended to improve postprandial 360 
glucose control following breakfast. This paradoxical second-meal phenomenon may relate to an 361 
influence of protein oxidation on the availability of hepatic and/or skeletal muscle glycogen and/or 362 
insulin sensitivity. 363 
 364 
 365 
 366 
 367 
 368 
 369 
 370 
 371 
 372 
 373 
 374 
 375 
 376 
 377 
 378 
 379 
 380 
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TABLES 408 
Table 1. Pre-breakfast and postprandial (120 min) values for substrate utilisation, RER and 409 
energy expenditure. At pre-breakfast n = 13 due to difficulties associated with expired air 410 
collection. *significant difference between CON v PRO. 411 
  CONTROL PROTEIN p 
Pre-breakfast    
 RER 0.88 ± 0.06 0.85 ± 0.05 0.102 
 CHO oxidation (g•min-1) 0.21 ± 0.10 0.18 ± 0.09 0.173 
 Lipid oxidation (g•min-1) 0.06 ± 0.02 0.07 ± 0.02 0.045* 
 Energy expenditure (kcal•day-1) 1901 ± 375 1952 ± 302 0.196 
Postprandial (120 min period)   
 RER 0.89 ± 0.03 0.89 ± 0.05 0.804 
 CHO oxidation (g•120 min-1) 28.17 ± 7.37 31.88 ± 12.29 0.084 
 Lipid oxidation (g•120 min-1) 6.85 ± 2.11 6.58 ± 2.75 0.694 
 Energy expenditure (kcal•120 min-1) 168 ± 27 179 ± 33 0.018* 
Carbohydrate (CHO), respiratory exchange ratio (RER). Values expressed as mean ± standard 412 
deviation. 413 
 414 
 415 
 416 
 417 
 418 
 419 
 420 
 421 
 422 
 423 
 424 
 425 
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Table 2. Pre-breakfast (0 min) and postprandial (60, 120 min) subjective appetite responses. 426 
Variable 0 min  60 min  120 min 
 CON PRO  CON PRO  CON PRO 
Hunger 42 ± 29 42 ± 28  27 ± 15 28 ± 21  40 ± 23 42 ± 23 
Fullness 34 ± 29 32 ± 31  60 ± 21 59 ± 23  54 ± 23 53 ± 23 
Satisfaction 38 ± 27 36 ± 28  63 ± 14 54 ± 24  52 ± 24 51 ± 24 
Prospective 
consumption 
55 ± 28 55 ± 28  33 ± 16 43 ± 20  47 ± 26 55 ± 26 
Combined 
appetite score 
57 ± 26 57 ± 24  34 ± 15 40 ± 18  45 ± 23 48 ± 20 
Control (CON), protein (PRO). All variables demonstrated a main effect of time (p<0.03). Values 427 
expressed as mean ± standard deviation. 428 
 429 
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FIGURE LEGENDS 592 
Figure 1. Amino acid profile of the whey protein used. 593 
 594 
Figure 2. Protocol schematic. A mixed macronutrient tolerance test was conducted following 595 
nocturnal ingestion of either protein (PRO) or water (CON).  596 
 597 
Figure 3.  A) Peak blood glucose concentration (conc.) and B) blood glucose iAUC. Dashed lines 598 
denote female (n = 7) and solid lines denote male (n = 7) participants. Darker lines represent 599 
individuals with a BMI >25 kg.m-2 (n = 4) and lighter lines denote those with a BMI <25 kg.m-2 600 
(n = 10). *significant difference between CON v PRO trials. 601 
 602 
Figure 4. Blood glucose concentration following breakfast ingestion at 0 min. The dashed line 603 
represents a blood glucose concentration of 7.5 mmol•L-1 as a reference threshold. 604 
 605 
 606 
 607 
 608 
 609 
 610 
 611 
 612 
 613 
 614 
 615 
 616 
 617 
